PATENT CLAIM ANALYSIS

Application Number: 16125359
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "264110"]

Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Claim (Index 38):
The compound of  claim 36  wherein R 3  is

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15093951', '15984855', '15353402', '15805716', '15721021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7553080909774555
- 35 USC 102 Novelty (BERT): 0.5304612921771413
- Combined Prediction Score: 0.7328234110974241
- Mean Citation Score: 287.438
- Max Citation Score: 306.9193
- Similarity Product: 186.7357168632209

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test